1 – 10 of 202
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2023
- Ferroptosis : friend or foe in cancer immunotherapy? (2023) ONCOIMMUNOLOGY. 12(1).
- 2022
- In vitro veritas : from 2D cultures to organ-on-a-chip models to study immunogenic cell death in the tumor microenvironment (2022) CELLS. 11(22).
- DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis (2022) CELL DEATH & DISEASE. 13(12).
- Immunogenic cell death and role of nanomaterials serving as therapeutic vaccine for personalized cancer immunotherapy (2022) FRONTIERS IN IMMUNOLOGY. 13.
- Perillaldehyde is a new ferroptosis inducer with a relevant clinical potential for acute myeloid leukemia therapy (2022) BIOMEDICINE & PHARMACOTHERAPY. 154.
- Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation (2022) FRONTIERS IN IMMUNOLOGY. 13.
- Which cell death modality wins the contest for photodynamic therapy of cancer? (2022) CELL DEATH & DISEASE. 13(5).
- Unraveling of functional activity of primary hippocampal neuron-glial networks in photodynamic therapy based on tetracyanotetra(aryl)porphyrazines (2022) CELLS. 11(7).
- Far-red fluorescent murine glioma model for accurate assessment of brain tumor progression (2022) CANCERS. 14(15).
- In vitro modelling of Marfan-related cardiomyopathy points to abnormalities in mechanobiology of the heart muscle cells (2022) 11th International Symposium on Marfan, Loeys-Dietz, and Related Conditions, Abstracts.